Mindfulness Intervention for HIV and Chronic Pain
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. However, you must not start any new treatments during the study.
Research shows that mindfulness-based treatments can help reduce pain intensity and improve quality of life for people with chronic pain. A study on Mindfulness-Based Stress Reduction (MBSR) found that participants with HIV reported improved pain and stress levels after practicing mindfulness, suggesting that similar mindfulness approaches like MORE could be beneficial.
12345The available research on mindfulness-based interventions, including Mindfulness-Based Stress Reduction (MBSR), suggests they are generally safe for humans, with no significant adverse effects reported in studies involving individuals with HIV and chronic pain.
13567Mindfulness-Oriented Recovery Enhancement (MORE) is unique because it combines mindfulness training with cognitive-behavioral techniques to help people with HIV manage chronic pain by focusing on present-moment awareness and emotional regulation, which is different from traditional pain treatments that often rely on medication.
348910Eligibility Criteria
This trial is for individuals living with HIV who also experience chronic pain. Specific eligibility details are not provided, but typically participants would need to meet certain health criteria and be able to commit to the study's requirements.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 2-hour version of Mindfulness-Oriented Recovery Enhancement (ONE MORE) training, divided into four 30-minute segments focusing on mindfulness, pain management, reappraisal, and savoring.
Follow-up
Participants are monitored for changes in pain, mindfulness, and other psychological measures over a 4-week period post-treatment.
Participant Groups
ONE Mindfulness-Oriented Recovery Enhancement is already approved in United States for the following indications:
- Chronic pain
- Opioid misuse
- Addiction
- Emotional distress